Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial
- 1 October 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 360 (9339) , 1050-1055
- https://doi.org/10.1016/s0140-6736(02)11141-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Immunology of TuberculosisAnnual Review of Immunology, 2001
- Randomized Controlled Trial ofMycobacterium vaccaeImmunotherapy in Non–Human Immunodeficiency Virus–Infected Ugandan Adults with Newly Diagnosed Pulmonary TuberculosisThe Journal of Infectious Diseases, 2000
- Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trialThe Lancet, 1999
- Cellular Immune Responses to Mycobacteria in Healthy and Human Immunodeficiency Virus–Positive Subjects in the United States After a Five‐Dose Schedule ofMycobacterium vaccaeVaccineClinical Infectious Diseases, 1998
- Immunization of Healthy Adult Subjects in the United States with Inactivated Mycobacterium vaccae Administered in a Three-Dose SeriesClinical Infectious Diseases, 1997
- Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 1. Newly-diagnosed pulmonary diseaseRespiratory Medicine, 1997
- Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in AfricaRespiratory Medicine, 1995
- A pilot study of immunotherapy with M. vaccae against tuberculosisTubercle and Lung Disease, 1994
- Human immunodeficiency virus type-1 infection in zambian children with tuberculosis: changing seroprevalance and evaluation of a thioacetazone-free regimenTubercle and Lung Disease, 1994
- Improved immunotherapy for pulmonary tuberculosis with Mycobacterium vaccaeTubercle, 1990